These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11271495)

  • 81. [Screening proteins related to retinoic acid resistance by proteomic analysis].
    Qin H; Liu T; Yang JL; Huang X; Liu B; Song X; Zhao X; Wei YQ
    Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(8):520-5. PubMed ID: 17459200
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Analysis of differential proteins in laryngeal carcinoma cell line Hep-2 with transfection of LCRG1].
    Zhang XP; Xiao ZQ; Chen ZC; Li C; Li JL; Yu YH; Ouyang YM; Feng XP; Zhang PF
    Ai Zheng; 2006 Jan; 25(1):22-8. PubMed ID: 16405744
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Induction of apoptosis and regression of spontaneous dog melanoma following in vivo application of synthetic cyclin-dependent kinase inhibitor olomoucine.
    Hajdúch M; Kolár Z; Novotný R; Hanus J; Mihál V; Hlobílková A; Nosková V; Strnad M
    Anticancer Drugs; 1997 Nov; 8(10):1007-13. PubMed ID: 9436644
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Protein pattern difference in the colon cancer cell lines examined by two-dimensional differential in-gel electrophoresis and mass spectrometry.
    Katayama M; Nakano H; Ishiuchi A; Wu W; Oshima R; Sakurai J; Nishikawa H; Yamaguchi S; Otsubo T
    Surg Today; 2006; 36(12):1085-93. PubMed ID: 17123137
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Cytokinin-derived cyclin-dependent kinase inhibitors: synthesis and cdc2 inhibitory activity of olomoucine and related compounds.
    Havlícek L; Hanus J; Veselý J; Leclerc S; Meijer L; Shaw G; Strnad M
    J Med Chem; 1997 Feb; 40(4):408-12. PubMed ID: 9046330
    [TBL] [Abstract][Full Text] [Related]  

  • 86. 5-Arylamino-2-methyl-4,7-dioxobenzothiazoles as inhibitors of cyclin-dependent kinase 4 and cytotoxic agents.
    Ryu CK; Kang HY; Lee SK; Nam KA; Hong CY; Ko WG; Lee BH
    Bioorg Med Chem Lett; 2000 Mar; 10(5):461-4. PubMed ID: 10743948
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Two-dimensional electrophoretic profiling of normal human kidney glomerulus proteome and construction of an extensible markup language (XML)-based database.
    Yoshida Y; Miyazaki K; Kamiie J; Sato M; Okuizumi S; Kenmochi A; Kamijo K; Nabetani T; Tsugita A; Xu B; Zhang Y; Yaoita E; Osawa T; Yamamoto T
    Proteomics; 2005 Mar; 5(4):1083-96. PubMed ID: 15668994
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Identification of the regulatory proteins in human pancreatic cancers treated with Trichostatin A by 2D-PAGE maps and multivariate statistical analysis.
    Marengo E; Robotti E; Cecconi D; Hamdan M; Scarpa A; Righetti PG
    Anal Bioanal Chem; 2004 Aug; 379(7-8):992-1003. PubMed ID: 15257427
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Cyclin-dependent kinase inhibitors attenuate protein hyperphosphorylation, cytoskeletal lesion formation, and motor defects in Niemann-Pick Type C mice.
    Zhang M; Li J; Chakrabarty P; Bu B; Vincent I
    Am J Pathol; 2004 Sep; 165(3):843-53. PubMed ID: 15331409
    [TBL] [Abstract][Full Text] [Related]  

  • 90. A purine analog kinase inhibitor, calcium/calmodulin-dependent protein kinase II inhibitor 59, reveals a role for calcium/calmodulin-dependent protein kinase II in insulin-stimulated glucose transport.
    Konstantopoulos N; Marcuccio S; Kyi S; Stoichevska V; Castelli LA; Ward CW; Macaulay SL
    Endocrinology; 2007 Jan; 148(1):374-85. PubMed ID: 17008397
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Development of an integrated approach for evaluation of 2-D gel image analysis: impact of multiple proteins in single spots on comparative proteomics in conventional 2-D gel/MALDI workflow.
    Yang Y; Thannhauser TW; Li L; Zhang S
    Electrophoresis; 2007 Jun; 28(12):2080-94. PubMed ID: 17486657
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Two-dimensional electrophoresis protein profiling as an analytical tool for human acute leukemia classification.
    Cui JW; Wang J; He K; Jin BF; Wang HX; Li W; Kang LH; Hu MR; Li HY; Yu M; Shen BF; Wang GJ; Zhang XM
    Electrophoresis; 2005 Jan; 26(1):268-79. PubMed ID: 15624164
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Fetal calf serum heat inactivation and lipopolysaccharide contamination influence the human T lymphoblast proteome and phosphoproteome.
    Rahman H; Qasim M; Schultze FC; Oellerich M; R Asif A
    Proteome Sci; 2011 Nov; 9(1):71. PubMed ID: 22085958
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Inhibition of type I insulin-like growth factor receptor tyrosine kinase by picropodophyllin induces apoptosis and cell cycle arrest in T lymphoblastic leukemia/lymphoma.
    Huang Z; Fang Z; Zhen H; Zhou L; Amin HM; Shi P
    Leuk Lymphoma; 2014 Aug; 55(8):1876-83. PubMed ID: 24206093
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Diverse effects of the cyclin-dependent kinase inhibitor bohemine: Concentration- and time-dependent suppression or stimulation of hybridoma culture.
    Franek F; Strnad M; Havlícek L; Siglerová V; Fismolová I; Eckschlager T
    Cytotechnology; 2001 Jul; 36(1-3):117-23. PubMed ID: 19003322
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Identification of triosephosphate isomerase as an anti-drug resistance agent in human gastric cancer cells using functional proteomic analysis.
    Wang X; Lu Y; Yang J; Shi Y; Lan M; Liu Z; Zhai H; Fan D
    J Cancer Res Clin Oncol; 2008 Sep; 134(9):995-1003. PubMed ID: 18309519
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Proteomics approach in classifying the biochemical basis of the anticancer activity of the new olomoucine-derived synthetic cyclin-dependent kinase inhibitor, bohemine.
    Kovárová H; Hajdúch M; Korínková G; Halada P; Krupicková S; Gouldsworthy A; Zhelev N; Strnad M
    Electrophoresis; 2000 Nov; 21(17):3757-64. PubMed ID: 11271495
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Application of proteomics in the search for novel proteins associated with the anti-cancer effect of the synthetic cyclin-dependent kinases inhibitor, bohemine.
    Kovarova H; Halada P; Man P; Dzubak P; Hajduch M
    Technol Cancer Res Treat; 2002 Aug; 1(4):247-56. PubMed ID: 12625783
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Protein fingerprints of anti-cancer effects of cyclin-dependent kinase inhibition: identification of candidate biomarkers using 2-D liquid phase separation coupled to mass spectrometry.
    Skalnikova H; Halada P; Dzubak P; Hajduch M; Kovarova H
    Technol Cancer Res Treat; 2005 Aug; 4(4):447-54. PubMed ID: 16029063
    [TBL] [Abstract][Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.